| Section |
Status |
BlueTeq |
Name |
| 08.03.04.02 |
Formulary
|
 |
Abiraterone tabs |
| 11.99.99.99 |
Formulary
|
|
Adalimumab injection uveitis |
| 13.05.03 |
Formulary
|
|
Adalimumab injection Hidradenitis suppurativa |
| 08.02.03 |
Formulary
|
|
Alemtuzumab injection multiple sclerosis |
| 10.01.04 |
Formulary
|
|
Anakinra injection Adult-Onset Still's Disease |
| 05.01.09 |
Formulary
|
|
Bedaquiline tabs Sirturo® |
| 10.01.03 |
Restricted Use
|
|
Belimumab injection |
| 08.01.01 |
Formulary
|
|
Bendamustine injection |
| 03.04.02 |
Formulary
|
|
Benralizumab injection |
| 08.02.03 |
Formulary
|
|
Blinatumomab injection |
| 08.01.05 |
Formulary
|
|
Bosutinib tabs |
| 08.01.05 |
Formulary
|
|
Brentuximab injection |
| 03.04.03 |
Formulary
|
|
C1 esterase inhibitor injection |
| 08.01.05 |
Formulary
|
|
Cabazitaxel injection |
| 08.01.05 |
Formulary
|
|
Cabozantinib tablets Cabometyx - renal carcinoma |
| 08.01.05 |
Formulary
|
|
Carfilzomib injection |
| 08.01.05 |
Formulary
|
|
Ceritinib caps |
| 08.01.05 |
Formulary
|
|
Cetuximab injection colorectal cancer |
| 08.01.05 |
Formulary
|
|
Cetuximab injection head and neck cancer |
| 08.02.04 |
Formulary
|
|
Cladribine tabs multiple sclerosis |
| 04.09.01 |
Formulary
|
|
Co-careldopa intestinal gel Duodopa® |
| 08.01.05 |
Formulary
|
|
Crizotinib caps |
| 05.03.03.02 |
Formulary
|
|
Daclatasvir tabs |
| 05.03.03.02 |
Formulary
|
|
Dasabuvir tabs |
| 08.01.05 |
Formulary
|
|
Dasatinib tabs |
| 02.08.01 |
Formulary
|
|
Defibrotide infusion |
| 05.01.09 |
Formulary
|
|
Delamanid tabs Deltyba® |
| 08.02.04 |
Formulary
|
|
Dimethyl fumarate caps Tecfidera - multiple sclerosis |
| 09.01.03 |
Formulary
|
|
Eculizumab injection Atypical Haemolytic Uraemic Syndrome [aHUS] |
| 09.01.03 |
Restricted Use
|
|
Eculizumab injection C3 glomerulopathy post-kidney transplant |
| 05.03.03.02 |
Formulary
|
|
Epclusa® tabs sofosbuvir and velpatasvir |
| 08.01.05 |
Formulary
|
|
Eribulin injection |
| 09.05.01.02 |
Formulary
|
|
Etelcalcetide injection |
| 08.01.05 |
Formulary
|
|
Everolimus tabs neuroendocrine tumours |
| 08.01.05 |
Formulary
|
|
Everolimus tabs breast cancer |
| 08.01.05 |
Formulary
|
|
Everolimus tabs renal cancer |
| 08.02.04 |
Formulary
|
|
Fingolimod caps |
| 08.02.04 |
Formulary
|
|
Glatiramer acetate injection |
| 05.03.03.02 |
Formulary
|
|
Harvoni® tabs sofosbuvir and ledipasvir |
| 08.01.05 |
Formulary
|
|
Ibrutinib caps |
| 08.02.04 |
Formulary
|
|
Interferon beta-1a injection multiple sclerosis |
| 08.02.04 |
Formulary
|
|
Interferon beta-1b injection multiple sclerosis |
| 03.07 |
Formulary
|
|
Mannitol inhalation powder Bronchitol® |
| 05.03.03.02 |
Formulary
|
|
Maviret® tabs glecaprevir and pibrentasvir |
| 03.04.02 |
Formulary
|
|
Mepolizumab injection |
| 08.02.04 |
Restricted Use
|
|
Natalizumab injection |
| 08.01.05 |
Formulary
|
|
Nilotinib caps |
| 03.11 |
Formulary
|
|
Nintedanib caps Ofev® - idiopathic pulmonary fibrosis |
| 08.01.05 |
Formulary
|
|
Nivolumab injection lung and urothelial cancer |
| 08.01.05 |
Formulary
|
|
Nivolumab injection haematological cancer |
| 08.01.05 |
Formulary
|
|
Nivolumab injection skin, head and neck and renal cancers |
| 01.09.01 |
Formulary
|
|
Obeticholic acid tabs |
| 08.02.04 |
Formulary
|
|
Ocrelizumab injection |
| 03.04.02 |
Restricted Use
|
|
Omalizumab injection asthma |
| 08.01.05 |
Formulary
|
|
Paclitaxel albumin injection Abraxane |
| 08.01.05 |
Formulary
|
|
Panitumumab injection |
| 08.03.04.03 |
Formulary
|
|
Pasireotide injection |
| 08.02.04 |
Formulary
|
|
Peginterferon beta-1a injection |
| 06.05.01 |
Formulary
|
|
Pegvisomant injection |
| 08.01.05 |
Formulary
|
|
Pembrolizumab injection lung cancer indications |
| 08.01.03 |
Formulary
|
|
Pemetrexed injection |
| 08.01.05 |
Formulary
|
|
Pertuzumab injection |
| 03.11 |
Formulary
|
|
Pirfenidone caps |
| 09.01.07 |
Restricted Use
|
|
Plerixafor injection |
| 08.02.04 |
Formulary
|
|
Pomalidomide caps |
| 08.01.05 |
Formulary
|
|
Ponatinib tabs |
| 03.04.02 |
Formulary
|
|
Reslizumab injection |
| 10.01.03 |
Restricted Use
|
|
Rituximab injection rheumatology - off-label indications |
| 10.01.03 |
Formulary
|
|
Rituximab injection ANCA vasculitis |
| 10.02.01 |
Formulary
|
|
Rituximab injection myaesthenia gravis - off-label |
| 05.03.03.02 |
Formulary
|
|
Simeprevir caps |
| 05.03.03.02 |
Formulary
|
|
Sofosbuvir tabs |
| 08.01.05 |
Formulary
|
|
Sorafenib tablets Hepatocellular carcinoma |
| 08.01.05 |
Formulary
|
|
Sunitinib caps neuroendocrine tumours |
| 08.02.04 |
Formulary
|
|
Teriflunomide tablets |
| 10.01.03 |
Formulary
|
|
Tocilizumab injection Adult-Onset Still's Disease |
| 10.01.03 |
Formulary
|
|
Tocilizumab subcutaneous injection giant cell arteritis |
| 08.01.05 |
Formulary
|
|
Trametinib tabs |
| 08.01.05 |
Formulary
|
|
Trastuzumab emtansine injection |
| 08.01.03 |
Formulary
|
|
Trifluridine–tipiracil tablets |
| 05.03.03.02 |
Formulary
|
|
Viekirax® ombitasvir with paritaprevir and ritonavir |
| 05.03.03.02 |
Formulary
|
|
Vosevi® tabs sofosbuvir, velpatasvir and voxilaprevir |
| 05.03.03.02 |
Formulary
|
|
Zepatier® tabs elbasvir and grazoprevir |
